Coronavirus (COVID-19) Advocacy
The ADA is lobbied Congress and the administration to protect dental patients and staff who are providing urgent and emergency care during the COVID-19 pandemic. The ADA is also lobbed to help dental practices stay viable during (and following) prolonged periods of reduced hours or closure. Visit ada.org to learn more about the Coronavirus (COVID-19) advocacy efforts.
FDA to pull prescription fluoride supplements from market
May 14, 2025
The FDA announced that it plans to remove prescription fluoride supplements from the market once a safety review is completed.
https://adanews.ada.org/ada-news/2025/may/fda-to-pull-prescription-fluoride-supplements-from-market/
